Classifica tra le azioni
#32717
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering... NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform. Among its key drug candidates, Acelarin is progressing through multiple clinical evaluations: a Phase I study for advanced solid tumors, Phase Ib trials for both recurrent ovarian cancer and biliary tract cancer, a Phase II trial targeting platinum-resistant ovarian cancer, and a pivotal Phase III trial for pancreatic cancer. NuCana is also developing NUC-3373, a ProTide derivative of 5-fluorouracil’s active anti-cancer metabolite. This compound is currently in a Phase I study for advanced solid tumors and a Phase Ib/2 trial for advanced colorectal cancer. Additionally, NUC-7738, a nucleoside analog, is undergoing Phase 1/2 clinical assessment for both advanced solid and hematological malignancies. To support its ProTide technology development, the company maintains research, collaboration, and licensing agreements with Cardiff University and University College Cardiff Consultants Ltd., covering the design, synthesis, characterization, and assessment of these compounds. Further collaborative and licensing arrangements are in place with Cardiff ProTides Ltd. Established in 1997, the company operated as NuCana BioMed Limited before rebranding to NuCana plc in August 2017. Its corporate headquarters are located in Edinburgh, United Kingdom.
Prezzo delle azioni
$1.53
Ultima sincronizzazione: 2026-08-18
Capitalizzazione di mercato
$9.29M
Variazione (1 giorno)
-1.29%
Variazione (1 anno)
-57.02%
Scambia NuCana plc (NCNA)
Margine operativo per NuCana plc (NCNA)
Margine operativo al 2026 TTM: 0.00%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di NuCana plc, il margine operativo attuale (TTM) è 0.00%. Alla fine del 2026, il margine operativo era 0.00%.
Storico del margine operativo per NuCana plc da 2026 a 2026
Margine operativo alla fine di ogni anno
| Anno |
Margine Operativo |
Cambia |
|
Non abbastanza dati per le date fornite. |
Margine operativo per aziende simili o concorrenti
| Azienda |
Margine Operativo |
Differenza del margine operativo |
Il paese |
|
|
38.59% |
-
|
US
|
|
|
28.81% |
-
|
NL
|
|
|
25.72% |
-
|
AU
|
|
|
0.00% |
-
|
CH
|
|
|
31.23% |
-
|
BE
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.
